MENU
+Compare
COCH
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$1.34
Change
+$0.02 (+1.52%)
Capitalization
85.34M

COCH Envoy Medical Forecast, Technical & Fundamental Analysis

Envoy Medical Inc is a hearing health company focused on providing medical technologies... Show more

COCH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for COCH with price predictions
Apr 17, 2025

COCH in -3.08% downward trend, declining for three consecutive days on April 10, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where COCH declined for three days, in of 132 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on COCH as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

COCH moved below its 50-day moving average on March 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for COCH entered a downward trend on April 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 44 cases where COCH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for COCH just turned positive on April 16, 2025. Looking at past instances where COCH's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COCH advanced for three days, in of 116 cases, the price rose further within the following month. The odds of a continued upward trend are .

COCH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.643) is normal, around the industry mean (23.907). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. COCH's P/S Ratio (357.143) is slightly higher than the industry average of (42.115).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. COCH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COCH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
COCH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
4875 White Bear Parkway
Phone
+1 877 900-3277
Employees
35
Web
https://www.envoymedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X85063.414000612.609400
+0.73%
Bitcoin cryptocurrency
SPY525.66N/A
N/A
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

COCH and Stocks

Correlation & Price change

A.I.dvisor tells us that COCH and VVOS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COCH and VVOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COCH
1D Price
Change %
COCH100%
+1.52%
VVOS - COCH
26%
Poorly correlated
+0.96%
ICAD - COCH
23%
Poorly correlated
+4.89%
FEMY - COCH
22%
Poorly correlated
+14.81%
ALC - COCH
22%
Poorly correlated
+0.53%
LMAT - COCH
22%
Poorly correlated
+1.90%
More